The company reported earnings per share of $2.63, while expectations were $2.48, according to Bloomberg's compilation.
The company's operating profit was also slightly better than expected, while revenue came in line with analysts' forecasts.
AstraZeneca beats expectations in second-quarter earnings report
Pharmaceutical giant AstraZeneca beats market expectations with its second-quarter interim report.
What do you think?